The growing healthcare industry at global as well as regional level forms the basis of our coherent and strategically structured market research reports. We segment our healthcare industry reports into Pharma, Vaccine, Biotech, Healthcare, and Generic Drugs. 

Our elaborate healthcare industry reports contain comprehensive analytical as well as statistical information on various issues, including cost analysis, intellectual property, infrastructure, healthcare equipment, health insurance market, and hospital services. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry, like contract manufacturing, clinical trials, drug delivery devices, and healthcare insurance.

Our research analysts evaluate data using sophisticated tools to provide viable and effective business solutions that help clients to plan their investment activities accordingly.

Indian Pharma Sector Forecast 2014 May, 2011  |  Pages : 105 The domestic pharmaceutical market is expected to register CAGR of around 15% during FY 2012 - FY 2014 to generate revenue worth around INR 986 Billion (US$ 19.7 Billion) by FY 2014...... read more Buy Now US$ 800.00 China Healthcare Sector Analysis Apr, 2011  |  Pages : 95 The total healthcare expenditure in China is anticipated to grow strongly at a CAGR of around 16% during the forecast period (2011-2013), thus reaching Yuan 3 Trillion by 2013 end.... read more Buy Now US$ 800.00 Middle East and Africa Pharma Sector Forecast to 2012 Apr, 2011  |  Pages : 80 The pharmaceutical market in the Middle East and Africa is forecasted to grow at a CAGR of around 9.5% during 2011-2013 to post a value worth around US$ 21 Billion by 2013 end.... read more Buy Now US$ 1200.00 South African Healthcare Market Analysis Apr, 2011  |  Pages : 75 South African pharmaceutical market is anticipated to grow at a CAGR of around 15.5% during 2011-2013 to post a value of US$ 4.6 Billion by the end of the forecast period.... read more Buy Now US$ 1000.00 UK Generics Market Analysis Apr, 2011  |  Pages : 55 The generics market in the UK is anticipated to grow at a CAGR of around 16% during 2011-2013 and will be worth GBP 6.5 Billion by 2013 end.... read more Buy Now US$ 800.00 US Stem Cell Market Analysis Apr, 2011  |  Pages : 65 With growing usage of stem cells in drugs development and increased government funding, the stem cell market is projected to grow at a CAGR of around 45% during 2011-2013.... read more Buy Now US$ 800.00 Booming US Generic Drug Market Mar, 2011  |  Pages : 60 The US generics market is anticipated to grow at a CAGR of around 10% during 2010-2013, with growth largely fuelled by the emergence of new products as patents of branded drugs are getting expired...... read more Buy Now US$ 1000.00 Global Contract Manufacturing Market Analysis Mar, 2011  |  Pages : 70 With the changing economic scenario and the pressure of reducing drugs manufacturing cost, the global contract manufacturing market is expected to grow at a CAGR of around 11% during 2011-2013...... read more Buy Now US$ 1500.00 Indian Contract Manufacturing - A Hot Opportunity Mar, 2011  |  Pages : 65 With the changing economic scenario and the pressure of reducing drugs manufacturing cost, Indian contract manufacturing market is expected to grow at a CAGR of around 45.5% during 2011-2013...... read more Buy Now US$ 900.00 Japanese Generic Market Forecast to 2013 Mar, 2011  |  Pages : 45 Backed by patent expiration of blockbuster drugs and active ingredients such as anastrozole, telmisartan, etc., generics market is projected to grow at a CAGR of around 8% during 2009-2013...... read more Buy Now US$ 800.00

Pages: Previous   1   2   3   4  5  6   7   8   9   Next   Page  5 of 9